IP Library › Assignment 070000/0010
Patent Assignment
Reel/Frame 070000/0010

Intellectual Property Security Agreement

Recorded: 2025-01-23 Pages: 9
Assignor
VIRACTA THERAPEUTICS, INC.
Executed: 2025-01-23
Assignee
OXFORD FINANCE LLC, AS COLLATERAL AGENT
115 SOUTH UNION ST, SUITE 300, ALEXANDRIA, VIRGINIA, 22314
Covered Properties (17)
Bruton's Tyrosine Kinase Inhibitors
Patent: 8,785,440 →
Application: 13/393,192 →
Publication: US 2012/0157443
Heterocyclic Compounds Useful as PDK1 Inhibitors
Patent: 9,546,165 →
Application: 13/499,835 →
Publication: US 2012/0208819
Bruton's Tyrosine Kinase Inhibitors
Patent: 9,249,146 →
Application: 14/316,710 →
Publication: US 2014/0309212
Pyrimidinyl Tyrosine Kinase Inhibitors
Patent: 9,394,277 →
Application: 14/406,315 →
Publication: US 2015/0158843
Heterocyclic Compounds Useful as PDK1 Inhibitors
Application: 14/966,821 →
Publication: US 2016/0331756
Bruton's Tyrosine Kinase Inhibitors
Patent: 9,790,229 →
Application: 15/006,061 →
Publication: US 2016/0376281
Pyrimidinyl Tyrosine Kinase Inhibitors
Patent: 9,944,622 →
Application: 15/196,389 →
Publication: US 2016/0304494
Bruton's Tyrosine Kinase Inhibitors
Application: 15/698,171 →
Publication: US 2018/0065974
Pyrimidinyl Tyrosine Kinase Inhibitors
Application: 15/911,546 →
Publication: US 2019/0047986
Succinate Forms and Compositions of Bruton's Tyrosine Kinase Inhibitors
Application: 16/319,506 →
Publication: US 2021/0032218
Pharmaceutical Formulations, Processes for Preparation, and Methods of Use
Application: 17/577,949 →
Publication: US 2022/0133718
Bruton's Tyrosine Kinase Inhibitors
Application: 18/505,940 →
Publication: US 2024/0246988
Heterocyclic PDK1 Inhibitors for Use to Treat Cancer
Application: 18/600,974 →
Publication: US 2024/0207258
Heterocyclic Compounds Useful as PDK1 Inhibitors
Application: 18/632,638 →
Publication: US 2024/0294524
Combination of Car T-Cell Therapy with Btk Inhibitors and Methods of Use Thereof
Application: 18/706,903 →
Publication: US 2026/0083848
Vecabrutinib for the Treatment of Graft-Versus-Host Disease
Application: 18/706,905 →
Pyrimidinyl Tyrosine Kinase Inhibitors
Application: 18/813,750 →
Publication: US 2024/0417389
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 27, 2012
From: CONLON, PATRICK; CUERVO, JULIO H.; GUAN, BING; HOPKINS, BRIAN T.
To: BIOGEN IDEC MA INC.
Reel/Frame 027939/0069 →
Assignment of Assignor's Interest Mar 27, 2012
From: BUI, MINNA; ERLANSON, DANIEL A.; FAN, JUNFA; ZHONG, MIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 027939/0193 →
Assignment of Assignor's Interest Apr 9, 2012
From: ERLANSON, DANIEL
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 028010/0212 →
Assignment of Assignor's Interest Apr 9, 2012
From: ARNDT, JOSEPH; CHAN, TIMOTHY; GUCKIAN, KEVIN; KUMARAVEL, GNANASAMBANDAM
To: BIOGEN IDEC MA INC.
Reel/Frame 028010/0180 →
Assignment of Assignor's Interest Apr 9, 2012
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 028013/0222 →
Confirmation of Joint Undivided Interest Mar 11, 2015
From: BIOGEN IDEC MA INC.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 035180/0433 →
Change of Name May 4, 2015
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 035571/0926 →
Assignment of Assignor's Interest Dec 28, 2015
From: BUI, MINNA; ERLANSON, DANIEL A.; FAN, JUNFA; ZHONG, MIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 037364/0264 →
Assignment of Assignor's Interest Dec 28, 2015
From: CONLON, PATRICK; CUERVO, JULIO H.; GUAN, BING; HOPKINS, BRIAN T.
To: BIOGEN IDEC MA INC.
Reel/Frame 037364/0244 →
Assignment of Assignor's Interest Aug 12, 2016
From: HOPKINS, BRIAN T.; CONLON, PATRICK; CHAN, TIMOTHY R.; JENKINS, TRACY J.
To: BIOGEN IDEC MA INC.
Reel/Frame 039423/0887 →
Assignment of Assignor's Interest Jul 18, 2017
From: CONLON, PATRICK; CUERVO, JULIO H.; GUAN, BING; HOPKINS, BRIAN T.
To: BIOGEN IDEC MA INC.
Reel/Frame 043035/0340 →
Change of Name Jul 18, 2017
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 043234/0119 →
Confirmation of Joint Undvided Interest Jul 18, 2017
From: BIOGEN IDEC MA INC.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 043234/0019 →
Change of Name Jul 18, 2017
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 043233/0933 →
Assignment of Assignor's Interest Jul 18, 2017
From: BUI, MINNA; ERLANSON, DANIEL A.; FAN, JUNFA; ZHONG, MIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 043035/0316 →
Assignment of Assignor's Interest Jul 21, 2017
From: ERLANSON, DANIEL
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 043064/0665 →
Assignment of Assignor's Interest Jul 21, 2017
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 043064/0716 →
Assignment of Assignor's Interest Jul 21, 2017
From: ARNDT, JOSEPH; CHAN, TIMOTHY; GUCKIAN, KEVIN; KUMARAVEL, GNANASAMBANDAM
To: BIOGEN IDEC MA INC.
Reel/Frame 043297/0540 →
Change of Name Sep 11, 2017
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 043814/0428 →
Assignment of Assignor's Interest Sep 11, 2017
From: CONLON, PATRICK; CUERVO, JULIO H.; GUAN, BING; HOPKINS, BRIAN T.
To: BIOGEN IDEC MA INC.
Reel/Frame 043547/0489 →
Assignment of Assignor's Interest Sep 11, 2017
From: BUI, MINNA; ERLANSON, DANIEL A.; FAN, JUNFA; ZHONG, MIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 043547/0365 →
Confirmation of Joint Undivided Interest Mar 6, 2018
From: BIOGEN IDEC MA INC.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 045511/0568 →
Assignment of Assignor's Interest Mar 6, 2018
From: HOPKINS, BRIAN T.; CONLON, PATRICK; CHAN, TIMOTHY R.; JENKINS, TRACY J.
To: BIOGEN IDEC MA INC.
Reel/Frame 045120/0834 →
Change of Name Mar 6, 2018
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 045511/0578 →
Assignment of Assignor's Interest Feb 11, 2019
From: MACPHEE, J. MICHAEL
To: BIOGEN MA INC.
Reel/Frame 048297/0119 →